Osteoporosis is a privilege systemic skeletal disease characterized by severely low general bone mass (bone hollowing). In this condition, bone composition does not change in quality, but it does decrease in quantity (
1). The risk of osteoporosis is higher in men during the first 3 to 5 years after inactivity due to increased bone loss rate (2 - 6.5% per year) (
2). Fracture caused by osteoporosis occurs in 60% of women and 30% of men aged over 60 years. Approximately one in three women and one in twelve men develops osteoporosis, leading to 10.000 debilitating fractures in patients. However, only a small number of these patients are evaluated (
3,
4). Therefore, increased bone resorption with disproportionate formation could result in decreased bone density and osteoporosis (
5). The bone regeneration process could be assessed using bone formation and bone resorption biomarkers. These biomarkers include bone matrix components, substances, and enzymes that are released during the regeneration process (
6). Alkaline phosphatase, osteocalcin, and parathormone hormone are the main biomarkers of the bone regeneration process (
7).
Alkaline phosphatase is a noble indicator of bone formation (
8). Alkaline phosphatase is a group of hydrolase enzymes produced by the kidneys, liver, and bones. Alkaline phosphatase is mainly attached to the cell membrane. The role of this enzyme is to remove the phosphate agent from phosphate-containing organic esters and to facilitate the movement of substances from the cell membrane. Hepatocyte cells produce these enzymes, and then they attach to the canalicular cell surface. Osteoblasts produce the bone isozymes responsible for breaking down pyrophosphate (an inhibitor of bone mineralization) (
9,
10). Osteocalcin is a specific bone protein circulating in the blood (
11).
Osteocalcin is characterized by the presence of carboxyglutamic acid residues, which are essential for the binding of osteocalcin to hydroxyapatites and bones (
12). Osteocalcin produced by osteoblasts is involved in calcium mineralization and homeostasis. Parathormone, which is secreted by the parathyroid gland, plays an important role in regulating blood calcium and osteocalcin, which are the important biomarkers of bone metabolism (
13). The parathyroid hormone is key to calcium homeostasis and bone metabolism (
13). This hormone is one of the main components of bone mass in adults and is closely related to bone loss, osteoporosis, and fractures. The secretion of this hormone is affected by calcium (
14). Regular and long-term physical activity can affect bone metabolism indices, prevent further bone desorption, reduce the secretion of parathyroid hormone, increase calcitonin, and prevent bone tissue from losing calcium and other minerals (
15). A number of studies evaluating bone biochemical markers have addressed the effect of exercise on bone metabolism (
16,
17), some of which have shown the anabolic effects of exercise on the bone (
17,
18), while others have demonstrated the negative effects of exercise on bone metabolism. Empirical evidence confirms that physical activity has positive effects on skeletal mass (
19), and relatively intense exercise lasting more than six months is more effective to increase bone density compared to high-repetition and low-pressure exercises (
20).
Despite the importance of alkaline phosphatase, osteocalcin, and parathormone levels in calcium and phosphorus metabolism and the significance of preserving bone salts (i.e., calcium and phosphorus) to prevent osteoporosis in inactive men and considering the possible role of long-term periodic aerobic training in changing these factors and maintain bone mass, the relationship between bone markers and bone density adaptations as an indicator of bone growth is not yet fully understood. Former studies have reported contradictory results regarding the response of bone metabolism markers, and optimal training cannot be suggested for maximum bone formation (
21).